| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 12/09/2008 | CA2462998C Novel estrogenic compounds |
| 12/04/2008 | WO2008145318A2 USE OF α, β-UNSATURATED CARBONYL COMPOUNDS AS QUENCHING REAGENTS FOR BIRCH REDUCTION |
| 12/04/2008 | DE102007025454A1 Verwendung von a,ß-ungesättigten Carbonylverbindungen als Quenchreagenzien für die Birch-Reduktion Use of alpha, beta-unsaturated carbonyl compounds as quench reagents for the Birch reduction |
| 12/03/2008 | CN101314611A Method for high-stereoselectivity preparation of 3 alpha or 7 alpha-methyl steroids |
| 12/02/2008 | US7459445 Estrogenic compounds and topical pharmaceutical formulations of the same |
| 11/20/2008 | US20080287404 High Purity 17Alpha-Cyanomethyl-17Beta-Hydroxy-Estra-4,9-Diene-3- One and Process For the Syntheses Thereof |
| 11/19/2008 | EP1805201B1 15beta-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY |
| 11/13/2008 | WO2008137048A1 Process for preparing aromatase inhibitors |
| 11/13/2008 | US20080281112 Diamine and polyamic acid derived therefrom for liquid crystal orientation applications |
| 11/13/2008 | CA2686312A1 Process for preparing aromatase inhibitors |
| 11/12/2008 | CN100432093C High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/11/2008 | US7449572 Reducing compound such as 3,3-ethylenedioxyestra-5(10), 9(11)-dien-17-ol, halogenating, epoxidation, alkylation, deprotecting, aromatization, saponification, neutralization to obtain compound such as 11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)-17-alpha-fluoroestra-1,3,5(10)-trien-3-ol |
| 11/06/2008 | WO2008134668A2 Heat-labile prodrugs |
| 11/06/2008 | US20080275259 Process for preparing aromatase inhibitors |
| 11/05/2008 | EP1223941B1 Therapeutic treatments for blood cell deficiencies using sreroids |
| 10/30/2008 | US20080269512 Large Scale Method for the deoxofluorination of ketones |
| 10/29/2008 | CN101296936A Process for production of steroid compound |
| 10/29/2008 | CN100429220C Methods and compositions for interferon therapy |
| 10/28/2008 | CA2167321C Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 10/22/2008 | CN101289487A 17 beta-amino steroidal estrogen and androst without blood coagulation activity and method for preparing same |
| 10/15/2008 | EP1980296A1 Method for purification of substances contaminated with organic chemicals |
| 10/14/2008 | US7435757 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
| 10/09/2008 | US20080249036 Antagonist Against Tolerance to Anticancer Drugs |
| 10/09/2008 | US20080248961 Removal of a compound from a mixture of related structures of a combinatorial library using a molecularly imprinted polymer as steroid adsorbents |
| 10/08/2008 | CN101282987A Glucocorticoid 16alpha,17alpha-isoxazolidines as anti-inflammatory agents |
| 10/07/2008 | CA2259532C Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 10/02/2008 | US20080242875 Degradation of polycyclic aromatic hydrocarbons to render them available for biodegradation |
| 10/01/2008 | CN100422206C Method for obtaining a natural mixture of conjugated equine estrogens |
| 10/01/2008 | CN100422204C 7-keto deoxy epiandrosterone and its acetate synthesizing method |
| 09/25/2008 | US20080234505 Aromatase inhibitor; deprotonation |
| 09/25/2008 | US20080234221 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 09/24/2008 | CN100420699C Process for the production of tibolone |
| 09/23/2008 | US7427610 e.g. 17 beta -Difluoromethyl-2-methoxy-estra-1,3,5(10)-trien-3-yl sulfamate; tubulin polymerization inhibitor; breast, prostate, colon, non-small-cell-lung cancer and primary dermal microvascular endothelial cell proliferation |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 09/11/2008 | US20080221074 Drug Screen and Treatment Method |
| 09/11/2008 | US20080220069 Long Acting Injectable Crystal Formulations of Estradiol Metabolites and Methods of Using Same |
| 09/10/2008 | EP1965880A1 A process for the isolation of pharmacologically active principles of vegetable and animal origin |
| 09/03/2008 | EP1962856A2 Medicament based on a monoester of steroids with long chain fatty acids |
| 09/02/2008 | US7419972 e.g. 3-Hydroxy-2-phenylethinyl-estra-1,3,5(10)-trien-17-one 19; anticarcinogenic, antitumor agent; hormone-dependent tumor disease of a male/female reproductive gland or endometriosis; estrogen-dependent diseases |
| 08/28/2008 | US20080207576 Substituted sapogenins and their use |
| 08/26/2008 | US7417140 17 beta -Hydroxy-7 alpha -(2'-hydroperoxy-2'-methoxyacetyl)pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone chemical intermediate useful to prepare eplerenone a hypotensive agent, useful for treating congestive heart failure |
| 08/26/2008 | CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/21/2008 | US20080200440 Progesterone receptor antagonists |
| 08/19/2008 | US7414127 7 α-Enedione-substituted steroid compounds |
| 08/19/2008 | US7414043 9-α-substituted estratrienes as selectively active estrogens |
| 08/14/2008 | US20080194812 Making drospirenone; chemical intermediates e.g. carbethoxy-drospirenone; industrial scale, safe (no chromium catalyst), meets purity requirements |
| 08/14/2008 | US20080194533 Sulfating 17 beta-dihydroequilin or 17 beta-estradiol using tertiary amine-sulfur trioxide complexes and sodium, lithium or potassium salt formation; hormone replacement therapy; hot flashes in postmenopausal women; endometriosis, breast cancer |
| 08/13/2008 | EP1955700A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/13/2008 | EP1339733B1 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 08/12/2008 | US7411062 17-Beta -hydroxy-7-alpha-(2'-oxoacetyl or alkanoylcarbonyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone; intermediate for preparing eplerenone |
| 08/07/2008 | US20080188675 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 08/07/2008 | US20080187947 Cholesterol-Mimetic Pyrene Probes |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/30/2008 | CN101229173A Contraceptive medicine based on a progestational agent and an oestrogen and preparation method |
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/24/2008 | US20080176824 Pharmaceutical Compositions 3 |
| 07/24/2008 | US20080176823 androgen receptor modulator; analogs of androst-5-ene-3 beta ,17 beta -diol ("AED") or 1,3,5(10)-estratriene-17 alpha -ethynyl-3 beta ,17 beta -diol ("EED") |
| 07/23/2008 | EP1947107A1 Process for production of steroid compound |
| 07/23/2008 | EP1946007A2 Anbrosteeone derivatives and method of use thereof |
| 07/23/2008 | EP1294382B1 7-hydroxyepiandrosterone having neuroprotective activity |
| 07/23/2008 | CN101228177A 3-ester prodrugs of estradiol |
| 07/23/2008 | CN101225099A Method for preparing compound containing 2,3-or3,4-double-bond steroid |
| 07/16/2008 | EP0630246B1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 07/10/2008 | US20080167283 Nandrolone 17 Beta-Carbonates |
| 07/09/2008 | CN101218245A 3-ester prodrugs of ethynylestradiol |
| 07/08/2008 | US7396827 Pharmaceutical compositions and treatment methods |
| 07/03/2008 | WO2008052709A3 Monoesters of estrogens with conjugated linoleic acid and uses thereof |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080159971 Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agent |
| 07/02/2008 | CN101209261A Natural sex hormone extracted by supercritical CO2 extraction method from pilose antler |
| 07/02/2008 | CN100398109C Steroid derived antibiotics |
| 06/26/2008 | US20080153797 Identifying compounds that can treat autoimmune conditions; ulcerative colitis, inflammatory bowel disease, Crohn's disease, psoriasis, actinic keratosis, arthritis, multiple sclerosis, optic neuritis |
| 06/26/2008 | US20080153792 Drug Identification and Treatment Method |
| 06/25/2008 | EP1936376A2 Screening and treatment methods for prevention of preterm delivery |
| 06/18/2008 | EP1931385A2 (s)-6-methyloxaalkyl exemestane compounds and related methods of use |
| 06/18/2008 | CN101199927A Preparing technological process of steroid 6 methylene stereoselectivity hydrogenation reaction catalyst |
| 06/17/2008 | US7388003 Δ15-D-Homosteroids with androgenic action |
| 06/12/2008 | US20080139519 Applying moist heat to a suspension of a labile glucocorticosteroid, in particular, budesonide or beclomethasone dipropionate, for a sterilizing-effective time; for preventing, reversing, and/or reducing symptoms of allergic and/or inflammatory conditions |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | CN100393741C Compounds with anti-inflammatory activity |
| 06/10/2008 | CA2302586C Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/05/2008 | WO2008067450A2 6-alkoxyalkyl estradiol derivatives and methods of use |
| 06/04/2008 | EP1927359A2 2-Methoxyestradiol for the treatment of inflammatory disorders |
| 06/03/2008 | US7381848 2-methoxyestradiol in a biodegradable polymer; administered for treatment of tumors |
| 06/03/2008 | US7381718 new process for the preparation of a key intermediate |
| 05/29/2008 | WO2008063128A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | CA2833976A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/29/2008 | CA2664126A1 The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of cns disorders |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/22/2008 | WO2008058767A1 Progesterone receptor antagonists |
| 05/22/2008 | US20080119447 6-alkoxyalkyl estradiol derivatives and methods of use |
| 05/22/2008 | US20080119446 a steroidal quinol that is converted to a biologically active estrogen compound via enzyme catalyzed reduction; 2-(1-adamantyl)-estra-1,3,5(10)-triene-3,17 beta -diol; estrogen receptors activator; low lipid solubility; cataract, glaucoma, conjunctivitis, diabetic retinopathy |
| 05/22/2008 | US20080119443 Certain lithocholic acid analogues that inhibit sialyltransferase |
| 05/22/2008 | CA2669767A1 Progesterone receptor antagonists |
| 05/21/2008 | EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/21/2008 | CN101182565A Extraction and purification method of 7 Alpha, 15Alpha-dihydroxy androstene alcohol ketone |
| 05/20/2008 | US7375098 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes |
| 05/15/2008 | US20080113925 Compositions and Methods for Increasing Telomerase Activity |